{"id":"https://openalex.org/W4365512115","doi":"https://doi.org/10.1158/1538-7445.am2023-ct252","title":"Abstract CT252: A modular, open-label, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and efficacy of EP0031, a next generation selective RET inhibitor, in patients with advanced RET-altered malignancies","display_name":"Abstract CT252: A modular, open-label, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and efficacy of EP0031, a next generation selective RET inhibitor, in patients with advanced RET-altered malignancies","publication_year":2023,"publication_date":"2023-04-14","ids":{"openalex":"https://openalex.org/W4365512115","doi":"https://doi.org/10.1158/1538-7445.am2023-ct252"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-ct252","doi":"https://doi.org/10.1158/1538-7445.am2023-ct252","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-ct252","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017054827","display_name":"Andrew George Gianoukakis","orcid":"https://orcid.org/0000-0002-8411-7059","observed_orcids":["https://orcid.org/0000-0002-8411-7059"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew G. Gianoukakis","raw_affiliation_strings":["1The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, and The David Geffen School of Medicine at UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, and The David Geffen School of Medicine at UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I177607063","https://openalex.org/I4210165985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030064179","display_name":"Susanne M. Arnold","orcid":"https://orcid.org/0000-0001-6542-9551","observed_orcids":["https://orcid.org/0000-0001-6542-9551"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanne Arnold","raw_affiliation_strings":["2University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100656048","display_name":"Saad A. Khan","orcid":"https://orcid.org/0000-0002-3440-9774","observed_orcids":["https://orcid.org/0000-0002-3440-9774"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saad Khan","raw_affiliation_strings":["3Stanford University, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Stanford University, San Francisco, CA;","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045462330","display_name":"Matthew John Taylor","orcid":"https://orcid.org/0000-0003-4716-4662","observed_orcids":["https://orcid.org/0000-0003-4716-4662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Taylor","raw_affiliation_strings":["4Providence Cancer Institute Franz Clinic, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Providence Cancer Institute Franz Clinic, Portland, OR;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012989377","display_name":"Hendrik\u2010Tobias Arkenau","orcid":"https://orcid.org/0000-0002-2015-1549","observed_orcids":["https://orcid.org/0000-0002-2015-1549","https://orcid.org/0000-0003-0372-0540"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hendrik-Tobias Arkenau","raw_affiliation_strings":["5Ellipses Pharma, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Ellipses Pharma, London, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111624485","display_name":"Liz Clark","orcid":"https://orcid.org/0009-0004-9271-1180","observed_orcids":["https://orcid.org/0009-0004-9271-1180"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liz Clark","raw_affiliation_strings":["5Ellipses Pharma, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Ellipses Pharma, London, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Geoffrey Fisher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey Fisher","raw_affiliation_strings":["5Ellipses Pharma, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Ellipses Pharma, London, United Kingdom;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043675371","display_name":"Vivek Subbiah","orcid":"https://orcid.org/0000-0002-6064-6837","observed_orcids":["https://orcid.org/0000-0002-6064-6837"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivek Subbiah","raw_affiliation_strings":["6MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"8_Supplement","first_page":"CT252","last_page":"CT252"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ret-inhibitors","display_name":"RET inhibitors","score":0.8190000057220459},{"id":"https://openalex.org/keywords/ret-fusion","display_name":"RET fusion","score":0.6179999709129333},{"id":"https://openalex.org/keywords/ret-mutations","display_name":"RET mutations","score":0.824999988079071},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5370000004768372},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9110000133514404},{"id":"https://openalex.org/keywords/medullary-thyroid-carcinoma","display_name":"medullary thyroid carcinoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/differentiated-thyroid-cancer","display_name":"differentiated thyroid cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.7770000100135803},{"id":"https://openalex.org/keywords/oral-small-molecule-inhibitor","display_name":"oral small-molecule inhibitor","score":0.5440000295639038},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7940000295639038},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.800000011920929},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9113047122955322},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8859237432479858},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5938031673431396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5689753293991089},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5559228658676147},{"id":"https://openalex.org/C2780120053","wikidata":"https://www.wikidata.org/wiki/Q3493538","display_name":"Medullary thyroid cancer","level":4,"score":0.4958866536617279},{"id":"https://openalex.org/C2779761222","wikidata":"https://www.wikidata.org/wiki/Q826522","display_name":"Thyroid cancer","level":3,"score":0.4704374670982361},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.463633269071579},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4585350453853607},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.393247127532959}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-ct252","doi":"https://doi.org/10.1158/1538-7445.am2023-ct252","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-ct252","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362578591","https://openalex.org/W4389239834","https://openalex.org/W4410804158","https://openalex.org/W4400108652","https://openalex.org/W4402558473","https://openalex.org/W7137891659","https://openalex.org/W7154726008","https://openalex.org/W7131796536","https://openalex.org/W4379283111","https://openalex.org/W7162543064"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Addressing":[2],"resistance":[3,77],"to":[4,59,78,97,121,129,154,157,317,374],"1st":[5,79,112,207,233],"generation":[6,34,73,80,208,234,386],"selective":[7,387],"RET":[8,22,42,109,267,388],"inhibitors":[9],"(SRI)":[10],"is":[11,65,94,117,144,152,163,315,330],"an":[12,69,161,261],"area":[13],"of":[14,21,31,45,56,114,167,180,195,219,255,260,273,323,339,382,399],"high":[15],"unmet":[16],"need,":[17],"with":[18,100,108,191,197,214,221,240,257,265,279,392],"a":[19,32,118,147,258,293,384],"number":[20],"dependent":[23],"and":[24,49,54,82,126,128,151,178,182,199,211,237,314,321,380,413],"independent":[25],"pathways":[26],"identified1,2.":[27],"The":[28,111],"ideal":[29],"profile":[30],"next":[33,72,385],"SRI":[35,209,235,243],"has":[36],"been":[37],"proposed:":[38],"broad":[39],"activity":[40],"against":[41],"fusions/mutations,":[43],"inhibition":[44],"both":[46],"V804M/L":[47],"gatekeeper":[48],"G810C/S/R":[50],"solvent":[51],"front":[52],"mutations":[53],"penetration":[55],"the":[57,115,131,176,283,309,376,400],"CNS":[58],"address":[60,76],"brain":[61,303],"metastases1,2.":[62],"This":[63,89],"trial":[64,329],"evaluating":[66],"whether":[67],"EP0031,":[68,181,383],"orally":[70],"available":[71],"SRI,":[74],"can":[75],"SRIs":[81],"improve":[83],"on":[84,146,206],"their":[85],"clinical":[86],"profile.":[87],"Methods:":[88],"Phase":[90,138,327],"1/2":[91],"study":[92,116,373],"(NCT05443126)":[93],"recruiting":[95],"up":[96,156],"265":[98],"patients":[99,171,196,213,220,239,290,391],"NSCLC,":[101],"thyroid":[102,201,227],"cancer":[103,202],"or":[104,250,275],"other":[105,222],"solid":[106,223,263,294],"tumors":[107],"aberrations.":[110],"part":[113],"dose":[119,134],"escalation":[120,143],"investigate":[122],"safety,":[123,377],"tolerability,":[124,378],"PK":[125],"PD":[127],"define":[130],"maximum":[132],"tolerated":[133],"(MTD)":[135],"and/or":[136],"Recommended":[137],"II":[139],"Dose":[140,142],"(RP2D).":[141],"based":[145],"rolling":[148],"6":[149],"design":[150],"expected":[153],"recruit":[155],"40":[158],"patients.":[159],"Once":[160],"RP2D":[162],"established,":[164],"expansion":[165,288],"cohorts":[166,194,218,289],"approximately":[168],"25":[169],"evaluable":[170],"each":[172],"will":[173],"further":[174],"explore":[175],"safety":[177],"tolerability":[179],"provide":[183],"preliminary":[184],"efficacy":[185,381],"data":[186],"in":[187,212,238,308,311,332,390],"selected":[188],"patient":[189],"populations":[190],"RET-altered":[192,394],"tumors:\u2022Four":[193],"NSCLC":[198],"medullary":[200],"who":[203,229],"have":[204,230,292],"progressed":[205,231],"therapy":[210],"no":[215,241,280],"prior":[216,242],"SRI\u2022Two":[217],"tumors,":[224],"including":[225],"differentiated":[226],"cancer,":[228],"following":[232],"therapy,":[236],"Key":[244],"inclusion":[245],"criteria":[246],"are":[247],"as":[248],"follows:\u2022Male":[249],"female":[251],"\u2265":[252],"18":[253],"years":[254],"age,":[256],"diagnosis":[259],"advanced":[262,393],"tumor":[264,295],"documented":[266],"altered":[268],"malignancy":[269],"\u2022ECOG":[270],"Performance":[271],"Status":[272],"0":[274],"1":[276],"at":[277],"screening":[278],"deterioration":[281],"over":[282],"previous":[284],"2":[285,410],"weeks.":[286],"For":[287],"must":[291],"measurable":[296],"by":[297],"RECIST":[298],"v1.1,":[299],"with/without":[300],"asymptomatic,":[301],"stable":[302],"metastases":[304],"Recruitment":[305],"was":[306],"initiated":[307],"US":[310],"November":[312],"2022":[313],"expanding":[316],"centers":[318],"across":[319],"Europe":[320],"rest":[322],"world.":[324],"A":[325,368],"parallel":[326],"I/II":[328,372],"ongoing":[331],"China":[333],"(A400,":[334],"NCT05265091,":[335],"Kelun":[336],"Biotech).":[337],"1Annals":[338],"Oncology":[340],"32(2)":[341],"S66":[342],"(2021)2Journal":[343],"Thoracic":[344],"Oncol":[345],"15(4)":[346],"542":[347],"(2020)":[348],"Citation":[349],"Format:":[350],"Andrew":[351],"G.":[352],"Gianoukakis,":[353],"Susanne":[354],"Arnold,":[355],"Saad":[356],"Khan,":[357],"Matthew":[358],"Taylor,":[359],"Hendrik-Tobias":[360],"Arkenau,":[361],"Liz":[362],"Clark,":[363],"Geoffrey":[364],"Fisher,":[365],"Vivek":[366],"Subbiah.":[367],"modular,":[369],"open-label,":[370],"phase":[371],"evaluate":[375],"pharmacokinetics":[379],"inhibitor,":[389],"malignancies":[395],"[abstract].":[396],"In:":[397],"Proceedings":[398],"American":[401],"Association":[402],"for":[403],"Cancer":[404,424],"Research":[405],"Annual":[406],"Meeting":[407],"2023;":[408],"Part":[409],"(Clinical":[411],"Trials":[412],"Late-Breaking":[414],"Research);":[415],"2023":[416],"Apr":[417],"14-19;":[418],"Orlando,":[419],"FL.":[420],"Philadelphia":[421],"(PA):":[422],"AACR;":[423],"Res":[425],"2023;83(8_Suppl):Abstract":[426],"nr":[427],"CT252.":[428]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-04-15T00:00:00"}